Immunic Names New CEO
Immunic appoints Erik Lundgren as CEO as it advances Phase 3 multiple sclerosis trials. This move may impact the company's strategic direction.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.